Pharma & Biotech
Zynerba in exciting run-up to clinical readouts on CBD skin gel Zygel to treat Fragile X syndrome
Seelos has catalysts for its ketamine depression drug, multiple shots on goal with a strong pipeline
GSRX Industries is smoking hot as its dispensaries and CBD products generate strong revenue
Only registered members can use this feature.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.